Gilead Appoints Sanofi’s Dietmar Berger as Chief Medical Officer
Dietmar Berger, former Sanofi CMO, joins Gilead Sciences in the same role, succeeding Merdad Parsey. Berger brings extensive drug development experience, bolstering Gilead’s focus on oncology and inflammatory diseases.
Gilead Appoints Sanofi’s Dietmar Berger as Chief Medical Officer Read More »